Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-04-18FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for glipizide from Apotex Corp., enabling the continued marketing of this generic antidiabetic medic…
-
FDA approval · 2017-04-05FDA Approved: RIOMET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for RIOMET (metformin hydrochloride) from Sun Pharmaceutical Industries.
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Glipizide and Metformin Hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of glipizide and metformin hydrochloride (Glipizide and Met…
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HCL, a fixed-dose combination tablet, by Heritage Pharmaceuticals (Avet)…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-04-04FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of glipizide and metformin hydrochloride (GLIPIZIDE AND MET…
-
FDA approval · 2017-03-16FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk. The entry indicates the supplement has b…
-
FDA approval · 2017-03-14FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2017-03-14FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Glyxambi (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., seekin…
-
FDA approval · 2017-03-14FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO XR (linagliptin and metformin hydrochloride), expanding its approved extended-rel…
-
FDA approval · 2017-03-01FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Dapagliflozin and Metformin Hydrochloride (Prasco Laboratories).
-
FDA approval · 2017-03-01FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca Pharmaceuticals LP. This action updates the drug's …
-
FDA approval · 2017-02-23FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved Metformin Hydrochloride as a generic drug under an Original Application (ANDA 202306) from Marlex Pharmaceuticals, Inc. This ex…
-
FDA approval · 2017-02-15FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Kazano, a fixed-dose combination of alogliptin and metformin hydrochloride, from Takeda Phar…
-
FDA approval · 2017-02-01FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET, the fixed-dose combination of canagliflozin and metformin hydrochloride, submitted by…
-
FDA approval · 2017-02-01FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, resulting in updated labeling…
-
FDA approval · 2017-01-27FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly, indicating an approved addition to the existing labeling…
-
FDA approval · 2017-01-18FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) to introduce its extended-release formulati…
-
FDA approval · 2017-01-18FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) submitted by Merck Sharp & Dohme LLC. The snippet does not specify the…
-
FDA approval · 2017-01-18FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin/metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2017-01-11FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA Inc, resulting in changes to the labeling.
-
FDA approval · 2017-01-10FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a dapagliflozin and metformin hydrochloride combination product, manufactured by Prasco Laborato…
-
FDA approval · 2017-01-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2017-01-06FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly, updating the product's labeling and approval detai…
-
FDA approval · 2017-01-06FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) by Eli Lilly and Company.